IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v15y2024i1d10.1038_s41467-024-49400-z.html
   My bibliography  Save this article

A scalable and cGMP-compatible autologous organotypic cell therapy for Dystrophic Epidermolysis Bullosa

Author

Listed:
  • Gernot Neumayer

    (School of Medicine
    School of Medicine)

  • Jessica L. Torkelson

    (School of Medicine
    School of Medicine)

  • Shengdi Li

    (Genome Biology Unit)

  • Kelly McCarthy

    (School of Medicine
    School of Medicine)

  • Hanson H. Zhen

    (School of Medicine
    School of Medicine)

  • Madhuri Vangipuram

    (School of Medicine
    School of Medicine)

  • Marius M. Mader

    (School of Medicine
    School of Medicine)

  • Gulilat Gebeyehu

    (Research and Development)

  • Taysir M. Jaouni

    (Research and Development)

  • Joanna Jacków-Malinowska

    (Columbia University
    King’s College London)

  • Avina Rami

    (Columbia University)

  • Corey Hansen

    (Columbia University)

  • Zongyou Guo

    (Columbia University)

  • Sadhana Gaddam

    (School of Medicine)

  • Keri M. Tate

    (School of Medicine)

  • Alberto Pappalardo

    (Columbia University)

  • Lingjie Li

    (School of Medicine)

  • Grace M. Chow

    (School of Medicine)

  • Kevin R. Roy

    (School of Medicine
    School of Medicine)

  • Thuylinh Michelle Nguyen

    (School of Medicine
    School of Medicine)

  • Koji Tanabe

    (I Peace Inc.)

  • Patrick S. McGrath

    (University of Colorado School of Medicine, Anschutz Medical Campus)

  • Amber Cramer

    (School of Medicine
    School of Medicine)

  • Anna Bruckner

    (University of Colorado School of Medicine, Anschutz Medical Campus)

  • Ganna Bilousova

    (University of Colorado School of Medicine, Anschutz Medical Campus)

  • Dennis Roop

    (University of Colorado School of Medicine, Anschutz Medical Campus)

  • Jean Y. Tang

    (School of Medicine
    School of Medicine)

  • Angela Christiano

    (Columbia University)

  • Lars M. Steinmetz

    (Genome Biology Unit
    School of Medicine
    School of Medicine)

  • Marius Wernig

    (School of Medicine
    School of Medicine
    School of Medicine)

  • Anthony E. Oro

    (School of Medicine
    School of Medicine)

Abstract

We present Dystrophic Epidermolysis Bullosa Cell Therapy (DEBCT), a scalable platform producing autologous organotypic iPS cell-derived induced skin composite (iSC) grafts for definitive treatment. Clinical-grade manufacturing integrates CRISPR-mediated genetic correction with reprogramming into one step, accelerating derivation of COL7A1-edited iPS cells from patients. Differentiation into epidermal, dermal and melanocyte progenitors is followed by CD49f-enrichment, minimizing maturation heterogeneity. Mouse xenografting of iSCs from four patients with different mutations demonstrates disease modifying activity at 1 month. Next-generation sequencing, biodistribution and tumorigenicity assays establish a favorable safety profile at 1-9 months. Single cell transcriptomics reveals that iSCs are composed of the major skin cell lineages and include prominent holoclone stem cell-like signatures of keratinocytes, and the recently described Gibbin-dependent signature of fibroblasts. The latter correlates with enhanced graftability of iSCs. In conclusion, DEBCT overcomes manufacturing and safety roadblocks and establishes a reproducible, safe, and cGMP-compatible therapeutic approach to heal lesions of DEB patients.

Suggested Citation

  • Gernot Neumayer & Jessica L. Torkelson & Shengdi Li & Kelly McCarthy & Hanson H. Zhen & Madhuri Vangipuram & Marius M. Mader & Gulilat Gebeyehu & Taysir M. Jaouni & Joanna Jacków-Malinowska & Avina Ra, 2024. "A scalable and cGMP-compatible autologous organotypic cell therapy for Dystrophic Epidermolysis Bullosa," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
    • Handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-49400-z
    DOI: 10.1038/s41467-024-49400-z
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-024-49400-z
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-024-49400-z?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Fatwa Adikusuma & Sandra Piltz & Mark A. Corbett & Michelle Turvey & Shaun R. McColl & Karla J. Helbig & Michael R. Beard & James Hughes & Richard T. Pomerantz & Paul Q. Thomas, 2018. "Large deletions induced by Cas9 cleavage," Nature, Nature, vol. 560(7717), pages 8-9, August.
    2. Benjamin Werner & Jack Case & Marc J. Williams & Ketevan Chkhaidze & Daniel Temko & Javier Fernández-Mateos & George D. Cresswell & Daniel Nichol & William Cross & Inmaculada Spiteri & Weini Huang & I, 2020. "Measuring single cell divisions in human tissues from multi-region sequencing data," Nature Communications, Nature, vol. 11(1), pages 1-9, December.
    3. Ann Collier & Angela Liu & Jessica Torkelson & Jillian Pattison & Sadhana Gaddam & Hanson Zhen & Tiffany Patel & Kelly McCarthy & Hana Ghanim & Anthony E. Oro, 2022. "Gibbin mesodermal regulation patterns epithelial development," Nature, Nature, vol. 606(7912), pages 188-196, June.
    4. Tobias Hirsch & Tobias Rothoeft & Norbert Teig & Johann W. Bauer & Graziella Pellegrini & Laura De Rosa & Davide Scaglione & Julia Reichelt & Alfred Klausegger & Daniela Kneisz & Oriana Romano & Aless, 2017. "Regeneration of the entire human epidermis using transgenic stem cells," Nature, Nature, vol. 551(7680), pages 327-332, November.
    5. Francesca Tucci & Stefania Galimberti & Luigi Naldini & Maria Grazia Valsecchi & Alessandro Aiuti, 2022. "A systematic review and meta-analysis of gene therapy with hematopoietic stem and progenitor cells for monogenic disorders," Nature Communications, Nature, vol. 13(1), pages 1-13, December.
    6. Ziguang Lin & Suoqin Jin & Jefferson Chen & Zhuorui Li & Zhongqi Lin & Li Tang & Qing Nie & Bogi Andersen, 2020. "Murine interfollicular epidermal differentiation is gradualistic with GRHL3 controlling progression from stem to transition cell states," Nature Communications, Nature, vol. 11(1), pages 1-15, December.
    7. Grégoire Cullot & Julian Boutin & Jérôme Toutain & Florence Prat & Perrine Pennamen & Caroline Rooryck & Martin Teichmann & Emilie Rousseau & Isabelle Lamrissi-Garcia & Véronique Guyonnet-Duperat & Al, 2019. "CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations," Nature Communications, Nature, vol. 10(1), pages 1-14, December.
    8. Igor Kogut & Sandra M. McCarthy & Maryna Pavlova & David P. Astling & Xiaomi Chen & Ana Jakimenko & Kenneth L. Jones & Andrew Getahun & John C. Cambier & Anna M. G. Pasmooij & Marcel F. Jonkman & Denn, 2018. "High-efficiency RNA-based reprogramming of human primary fibroblasts," Nature Communications, Nature, vol. 9(1), pages 1-15, December.
    9. Jennifer A. Doudna, 2020. "The promise and challenge of therapeutic genome editing," Nature, Nature, vol. 578(7794), pages 229-236, February.
    10. Elena Enzo & Alessia Secone Seconetti & Mattia Forcato & Elena Tenedini & Maria Pia Polito & Irene Sala & Sonia Carulli & Roberta Contin & Clelia Peano & Enrico Tagliafico & Silvio Bicciato & Sergio B, 2021. "Single-keratinocyte transcriptomic analyses identify different clonal types and proliferative potential mediated by FOXM1 in human epidermal stem cells," Nature Communications, Nature, vol. 12(1), pages 1-15, December.
    11. Pinar Akcakaya & Maggie L. Bobbin & Jimmy A. Guo & Jose Malagon-Lopez & Kendell Clement & Sara P. Garcia & Mick D. Fellows & Michelle J. Porritt & Mike A. Firth & Alba Carreras & Tania Baccega & Frank, 2018. "In vivo CRISPR editing with no detectable genome-wide off-target mutations," Nature, Nature, vol. 561(7723), pages 416-419, September.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Burcu Bestas & Sandra Wimberger & Dmitrii Degtev & Alexandra Madsen & Antje K. Rottner & Fredrik Karlsson & Sergey Naumenko & Megan Callahan & Julia Liz Touza & Margherita Francescatto & Carl Ivar Möl, 2023. "A Type II-B Cas9 nuclease with minimized off-targets and reduced chromosomal translocations in vivo," Nature Communications, Nature, vol. 14(1), pages 1-15, December.
    2. Jianli Tao & Daniel E. Bauer & Roberto Chiarle, 2023. "Assessing and advancing the safety of CRISPR-Cas tools: from DNA to RNA editing," Nature Communications, Nature, vol. 14(1), pages 1-16, December.
    3. Michael Kosicki & Felicity Allen & Frances Steward & Kärt Tomberg & Yangyang Pan & Allan Bradley, 2022. "Cas9-induced large deletions and small indels are controlled in a convergent fashion," Nature Communications, Nature, vol. 13(1), pages 1-11, December.
    4. Angelo Miskalis & Shraddha Shirguppe & Jackson Winter & Gianna Elias & Devyani Swami & Ananthan Nambiar & Michelle Stilger & Wendy S. Woods & Nicholas Gosstola & Michael Gapinske & Alejandra Zeballos , 2024. "SPLICER: a highly efficient base editing toolbox that enables in vivo therapeutic exon skipping," Nature Communications, Nature, vol. 15(1), pages 1-16, December.
    5. G. Cullot & J. Boutin & S. Fayet & F. Prat & J. Rosier & D. Cappellen & I. Lamrissi & P. Pennamen & J. Bouron & S. Amintas & C. Thibault & I. Moranvillier & E. Laharanne & J. P. Merlio & V. Guyonnet-D, 2023. "Cell cycle arrest and p53 prevent ON-target megabase-scale rearrangements induced by CRISPR-Cas9," Nature Communications, Nature, vol. 14(1), pages 1-16, December.
    6. Jianhang Yin & Kailun Fang & Yanxia Gao & Liqiong Ou & Shaopeng Yuan & Changchang Xin & Weiwei Wu & Wei-wei Wu & Jiaxu Hong & Hui Yang & Jiazhi Hu, 2022. "Safeguarding genome integrity during gene-editing therapy in a mouse model of age-related macular degeneration," Nature Communications, Nature, vol. 13(1), pages 1-8, December.
    7. Jianli Tao & Qi Wang & Carlos Mendez-Dorantes & Kathleen H. Burns & Roberto Chiarle, 2022. "Frequency and mechanisms of LINE-1 retrotransposon insertions at CRISPR/Cas9 sites," Nature Communications, Nature, vol. 13(1), pages 1-17, December.
    8. Jianhang Yin & Rusen Lu & Changchang Xin & Yuhong Wang & Xinyu Ling & Dong Li & Weiwei Zhang & Mengzhu Liu & Wutao Xie & Lingyun Kong & Wen Si & Ping Wei & Bingbing Xiao & Hsiang-Ying Lee & Tao Liu & , 2022. "Cas9 exo-endonuclease eliminates chromosomal translocations during genome editing," Nature Communications, Nature, vol. 13(1), pages 1-14, December.
    9. Changchang Xin & Jianhang Yin & Shaopeng Yuan & Liqiong Ou & Mengzhu Liu & Weiwei Zhang & Jiazhi Hu, 2022. "Comprehensive assessment of miniature CRISPR-Cas12f nucleases for gene disruption," Nature Communications, Nature, vol. 13(1), pages 1-10, December.
    10. Bert van de Kooij & Alex Kruswick & Haico van Attikum & Michael B. Yaffe, 2022. "Multi-pathway DNA-repair reporters reveal competition between end-joining, single-strand annealing and homologous recombination at Cas9-induced DNA double-strand breaks," Nature Communications, Nature, vol. 13(1), pages 1-17, December.
    11. Jun Huang & David Rowe & Pratima Subedi & Wei Zhang & Tyler Suelter & Barbara Valent & David E. Cook, 2022. "CRISPR-Cas12a induced DNA double-strand breaks are repaired by multiple pathways with different mutation profiles in Magnaporthe oryzae," Nature Communications, Nature, vol. 13(1), pages 1-18, December.
    12. Elle Koren & Alona Feldman & Marianna Yusupova & Avihay Kadosh & Egor Sedov & Roi Ankawa & Yahav Yosefzon & Waseem Nasser & Stefanie Gerstberger & Liam B. Kimel & Noa Priselac & Samara Brown & Sam Sha, 2022. "Thy1 marks a distinct population of slow-cycling stem cells in the mouse epidermis," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    13. Lukas Möller & Eric J. Aird & Markus S. Schröder & Lena Kobel & Lucas Kissling & Lilly van de Venn & Jacob E. Corn, 2022. "Recursive Editing improves homology-directed repair through retargeting of undesired outcomes," Nature Communications, Nature, vol. 13(1), pages 1-10, December.
    14. Raed Ibraheim & Phillip W. L. Tai & Aamir Mir & Nida Javeed & Jiaming Wang & Tomás C. Rodríguez & Suk Namkung & Samantha Nelson & Eraj Shafiq Khokhar & Esther Mintzer & Stacy Maitland & Zexiang Chen &, 2021. "Self-inactivating, all-in-one AAV vectors for precision Cas9 genome editing via homology-directed repair in vivo," Nature Communications, Nature, vol. 12(1), pages 1-17, December.
    15. Xiangyang Li & Guiquan Zhang & Shisheng Huang & Yao Liu & Jin Tang & Mingtian Zhong & Xin Wang & Wenjun Sun & Yuan Yao & Quanjiang Ji & Xiaolong Wang & Jianghuai Liu & Shiqiang Zhu & Xingxu Huang, 2023. "Development of a versatile nuclease prime editor with upgraded precision," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    16. Xiangfeng Kong & Hainan Zhang & Guoling Li & Zikang Wang & Xuqiang Kong & Lecong Wang & Mingxing Xue & Weihong Zhang & Yao Wang & Jiajia Lin & Jingxing Zhou & Xiaowen Shen & Yinghui Wei & Na Zhong & W, 2023. "Engineered CRISPR-OsCas12f1 and RhCas12f1 with robust activities and expanded target range for genome editing," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    17. Stamatis Papathanasiou & Styliani Markoulaki & Logan J. Blaine & Mitchell L. Leibowitz & Cheng-Zhong Zhang & Rudolf Jaenisch & David Pellman, 2021. "Whole chromosome loss and genomic instability in mouse embryos after CRISPR-Cas9 genome editing," Nature Communications, Nature, vol. 12(1), pages 1-7, December.
    18. Péter István Kulcsár & András Tálas & Zoltán Ligeti & Eszter Tóth & Zsófia Rakvács & Zsuzsa Bartos & Sarah Laura Krausz & Ágnes Welker & Vanessza Laura Végi & Krisztina Huszár & Ervin Welker, 2023. "A cleavage rule for selection of increased-fidelity SpCas9 variants with high efficiency and no detectable off-targets," Nature Communications, Nature, vol. 14(1), pages 1-20, December.
    19. Meiling Lu & Chenlin Yu & Yuwen Zhang & Wenjun Ju & Zhi Ye & Chenyang Hua & Jinze Mao & Chunyi Hu & Zhenhuang Yang & Yibei Xiao, 2024. "Structure and genome editing of type I-B CRISPR-Cas," Nature Communications, Nature, vol. 15(1), pages 1-12, December.
    20. Ju-Chan Park & Yun-Jeong Kim & Gue-Ho Hwang & Chan Young Kang & Sangsu Bae & Hyuk-Jin Cha, 2024. "Enhancing genome editing in hPSCs through dual inhibition of DNA damage response and repair pathways," Nature Communications, Nature, vol. 15(1), pages 1-11, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-49400-z. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.